Prof. Israel Amirav, MD, is a pediatric pulmonologist with longstanding clinical and research expertise in pediatric aerosol medicine, inhalation therapy, and respiratory drug delivery in infants and young children. He has held academic appointments in pediatrics and pediatric pulmonology, including at the University of Alberta, and currently works at Dana-Dwek Children’s Hospital, Tel Aviv.

Prof. Amirav’s research has focused extensively on the practical and clinical challenges of aerosol delivery in children, including the use of pressurized metered-dose inhalers, valved holding chambers, spacers, facemasks, nebulizers, and pediatric delivery interfaces. His work has addressed key determinants of effective drug delivery in young children, such as mask seal, interface fit, breathing pattern, caregiver technique, crying, cooperation, and the gap between in vitro aerosol performance and real-world clinical effectiveness.

He has co-authored numerous publications in pediatric aerosol therapy and respiratory medicine, including studies and reviews on inhaled drug delivery, facemask design, spacer use, and aerosol treatment in infants and preschool children. Together with collaborators, he has also contributed to innovations in pediatric delivery interfaces, including child-friendly mask concepts designed to improve acceptance and lung delivery.

In addition to his aerosol work, Prof. Amirav is involved in research on preschool asthma, respiratory distress assessment, primary ciliary dyskinesia, and digital respiratory monitoring. His current interests include patient-centric respiratory device development, real-world evidence, and the integration of clinical insight into the design and evaluation of inhaled therapies for young children.